US Tech 100

19,636.04

0.55%

Get Started

DRIO DarioHealth Corporation

0.72

-0.006 (-0.83%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Feb 2025 to Mar 2025

DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Mar 2024 to Mar 2025

DarioHealth Corporation News

Form 3 - Initial statement of beneficial ownership of securities
Friday 7 March 2025 (2 days ago) • Edgar (US Regulatory)

Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula
Friday 7 March 2025 (2 days ago) • PR Newswire (US)

Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth
Wednesday 5 March 2025 (4 days ago) • PR Newswire (US)

DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025
Tuesday 4 March 2025 (5 days ago) • PR Newswire (US)

Form PRE 14A - Other preliminary proxy statements
Friday 28 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

DarioHealth Appoints Healthcare Industry Leader Larry Leisure to Board of Directors
Thursday 27 February 2025 (1 week ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
Friday 7 February 2025 (1 month ago) • Business Wire

DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base
Thursday 6 February 2025 (1 month ago) • PR Newswire (US)

PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
Thursday 30 January 2025 (1 month ago) • Business Wire

Form 8-K - Current report
Wednesday 22 January 2025 (2 months ago) • Edgar (US Regulatory)

More DarioHealth Corporation News Articles

NASDAQ

CLBS

Caladrius Biosciences

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

DRIO DarioHealth Corporation

DarioHealth Corporation News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

DRIO DarioHealth Corporation

DarioHealth Corporation News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free